Concepts (547)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reading | 21 | 2016 | 115 | 5.650 |
Why?
| | Child | 69 | 2016 | 880 | 4.360 |
Why?
| | Humans | 128 | 2016 | 7258 | 3.940 |
Why?
| | Language Development Disorders | 13 | 2015 | 27 | 3.910 |
Why?
| | Genetic Predisposition to Disease | 23 | 2015 | 64 | 3.690 |
Why?
| | Dyslexia | 18 | 2014 | 115 | 3.360 |
Why?
| | Cognition | 15 | 2016 | 179 | 3.200 |
Why?
| | Polymorphism, Single Nucleotide | 17 | 2016 | 58 | 3.100 |
Why?
| | Adolescent | 49 | 2016 | 1090 | 2.910 |
Why?
| | Brain | 13 | 2016 | 333 | 2.760 |
Why?
| | Male | 70 | 2016 | 4565 | 2.750 |
Why?
| | Juvenile Delinquency | 9 | 2015 | 17 | 2.670 |
Why?
| | Female | 60 | 2016 | 4162 | 2.380 |
Why?
| | Phonetics | 12 | 2014 | 58 | 2.120 |
Why?
| | Catechol O-Methyltransferase | 9 | 2013 | 13 | 2.100 |
Why?
| | Autistic Disorder | 10 | 2011 | 29 | 1.990 |
Why?
| | Learning Disorders | 8 | 2015 | 86 | 1.990 |
Why?
| | Epigenesis, Genetic | 7 | 2016 | 18 | 1.900 |
Why?
| | Intelligence | 11 | 2014 | 72 | 1.840 |
Why?
| | Polymorphism, Genetic | 14 | 2013 | 54 | 1.820 |
Why?
| | Genotype | 18 | 2016 | 101 | 1.650 |
Why?
| | Mental Disorders | 7 | 2015 | 96 | 1.600 |
Why?
| | Child Language | 6 | 2015 | 15 | 1.590 |
Why?
| | DNA Methylation | 5 | 2016 | 25 | 1.560 |
Why?
| | Comprehension | 6 | 2014 | 16 | 1.520 |
Why?
| | Child Development | 4 | 2015 | 41 | 1.510 |
Why?
| | Gene Expression Profiling | 8 | 2016 | 100 | 1.470 |
Why?
| | Speech Perception | 5 | 2013 | 27 | 1.410 |
Why?
| | Phenotype | 17 | 2015 | 165 | 1.410 |
Why?
| | Prisoners | 5 | 2013 | 18 | 1.340 |
Why?
| | Language Disorders | 4 | 2016 | 20 | 1.330 |
Why?
| | Genetic Linkage | 8 | 2011 | 20 | 1.280 |
Why?
| | Models, Psychological | 7 | 2012 | 103 | 1.270 |
Why?
| | Adolescent Development | 3 | 2016 | 9 | 1.250 |
Why?
| | Child Development Disorders, Pervasive | 5 | 2015 | 23 | 1.230 |
Why?
| | Frontal Lobe | 3 | 2016 | 30 | 1.140 |
Why?
| | Induced Pluripotent Stem Cells | 4 | 2015 | 6 | 1.130 |
Why?
| | Social Environment | 7 | 2012 | 49 | 1.130 |
Why?
| | Haplotypes | 13 | 2013 | 24 | 1.100 |
Why?
| | Genomics | 3 | 2015 | 26 | 1.100 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2016 | 46 | 1.080 |
Why?
| | Conduct Disorder | 3 | 2015 | 9 | 1.020 |
Why?
| | Genetic Variation | 9 | 2013 | 64 | 1.000 |
Why?
| | Endophenotypes | 3 | 2012 | 3 | 1.000 |
Why?
| | Young Adult | 13 | 2016 | 690 | 0.990 |
Why?
| | Neurons | 8 | 2016 | 302 | 0.980 |
Why?
| | Gene Frequency | 13 | 2016 | 34 | 0.970 |
Why?
| | Adult | 23 | 2016 | 2487 | 0.950 |
Why?
| | Developmental Disabilities | 3 | 2014 | 23 | 0.950 |
Why?
| | Mental Health | 3 | 2015 | 26 | 0.940 |
Why?
| | Linkage Disequilibrium | 12 | 2011 | 17 | 0.930 |
Why?
| | Russia | 12 | 2016 | 24 | 0.920 |
Why?
| | Genome-Wide Association Study | 4 | 2016 | 14 | 0.920 |
Why?
| | Creativity | 3 | 2016 | 12 | 0.920 |
Why?
| | Cross-Cultural Comparison | 5 | 2016 | 23 | 0.910 |
Why?
| | Neurodevelopmental Disorders | 2 | 2015 | 2 | 0.870 |
Why?
| | Child, Preschool | 12 | 2016 | 289 | 0.840 |
Why?
| | Models, Genetic | 9 | 2013 | 69 | 0.830 |
Why?
| | Social Adjustment | 2 | 2016 | 17 | 0.830 |
Why?
| | Learning | 4 | 2016 | 70 | 0.830 |
Why?
| | Education, Special | 4 | 2012 | 20 | 0.830 |
Why?
| | Parenting | 2 | 2016 | 20 | 0.820 |
Why?
| | Gene-Environment Interaction | 3 | 2015 | 3 | 0.820 |
Why?
| | Antisocial Personality Disorder | 2 | 2015 | 6 | 0.810 |
Why?
| | Magnetic Resonance Imaging | 8 | 2016 | 249 | 0.790 |
Why?
| | Child Behavior | 3 | 2014 | 30 | 0.780 |
Why?
| | Awareness | 5 | 2013 | 32 | 0.770 |
Why?
| | Child Abuse | 2 | 2014 | 12 | 0.750 |
Why?
| | Genetic Association Studies | 6 | 2015 | 16 | 0.740 |
Why?
| | Language Tests | 8 | 2015 | 28 | 0.730 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 4 | 2012 | 62 | 0.720 |
Why?
| | Risk Factors | 10 | 2015 | 354 | 0.710 |
Why?
| | Teaching | 4 | 2011 | 33 | 0.700 |
Why?
| | Students | 2 | 2016 | 87 | 0.700 |
Why?
| | Speech | 3 | 2012 | 17 | 0.700 |
Why?
| | Writing | 2 | 2016 | 10 | 0.690 |
Why?
| | Macrophage Migration-Inhibitory Factors | 2 | 2014 | 5 | 0.670 |
Why?
| | Personality Assessment | 4 | 2010 | 23 | 0.670 |
Why?
| | Brain Mapping | 5 | 2012 | 130 | 0.660 |
Why?
| | Attention | 2 | 2014 | 142 | 0.650 |
Why?
| | Linguistics | 3 | 2015 | 8 | 0.650 |
Why?
| | Language | 2 | 2014 | 63 | 0.640 |
Why?
| | Aptitude | 4 | 2014 | 13 | 0.630 |
Why?
| | Depression | 3 | 2012 | 111 | 0.630 |
Why?
| | Aging | 4 | 2012 | 173 | 0.630 |
Why?
| | Aggression | 2 | 2012 | 15 | 0.630 |
Why?
| | Sequence Analysis, DNA | 4 | 2016 | 73 | 0.620 |
Why?
| | Surveys and Questionnaires | 5 | 2015 | 350 | 0.610 |
Why?
| | Alleles | 10 | 2011 | 43 | 0.610 |
Why?
| | Genome, Human | 4 | 2012 | 31 | 0.600 |
Why?
| | Speech Disorders | 3 | 2010 | 8 | 0.600 |
Why?
| | Adaptation, Psychological | 3 | 2014 | 123 | 0.590 |
Why?
| | Rural Population | 3 | 2015 | 15 | 0.590 |
Why?
| | Temporal Lobe | 3 | 2012 | 39 | 0.580 |
Why?
| | Dopamine beta-Hydroxylase | 3 | 2015 | 5 | 0.580 |
Why?
| | Genetic Testing | 3 | 2015 | 9 | 0.570 |
Why?
| | Child Behavior Disorders | 3 | 2010 | 22 | 0.550 |
Why?
| | Gene Expression | 4 | 2013 | 148 | 0.540 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2012 | 122 | 0.530 |
Why?
| | Genetic Diseases, Inborn | 2 | 2015 | 2 | 0.530 |
Why?
| | Animals | 12 | 2016 | 3827 | 0.530 |
Why?
| | Family | 3 | 2012 | 34 | 0.530 |
Why?
| | Achievement | 3 | 2014 | 59 | 0.530 |
Why?
| | Middle Aged | 10 | 2016 | 1841 | 0.520 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2013 | 59 | 0.520 |
Why?
| | Continental Population Groups | 3 | 2015 | 25 | 0.520 |
Why?
| | Language Development | 2 | 2015 | 18 | 0.520 |
Why?
| | Neocortex | 2 | 2012 | 6 | 0.510 |
Why?
| | Nerve Tissue Proteins | 3 | 2015 | 81 | 0.510 |
Why?
| | Decision Making | 3 | 2013 | 40 | 0.510 |
Why?
| | Neuropsychological Tests | 8 | 2015 | 367 | 0.500 |
Why?
| | Mothers | 2 | 2014 | 14 | 0.500 |
Why?
| | Mother-Child Relations | 2 | 2016 | 11 | 0.500 |
Why?
| | Promoter Regions, Genetic | 4 | 2011 | 142 | 0.500 |
Why?
| | Evoked Potentials | 2 | 2015 | 64 | 0.500 |
Why?
| | Longitudinal Studies | 7 | 2016 | 154 | 0.500 |
Why?
| | Forkhead Transcription Factors | 2 | 2015 | 9 | 0.490 |
Why?
| | Genetics, Population | 4 | 2005 | 15 | 0.490 |
Why?
| | Individuality | 4 | 2014 | 33 | 0.490 |
Why?
| | Chromosomes, Human, Pair 6 | 4 | 2003 | 6 | 0.490 |
Why?
| | Depressive Disorder | 3 | 2008 | 54 | 0.470 |
Why?
| | Reaction Time | 3 | 2013 | 172 | 0.460 |
Why?
| | Monoamine Oxidase | 3 | 2010 | 8 | 0.460 |
Why?
| | Zambia | 5 | 2015 | 9 | 0.460 |
Why?
| | Exome | 1 | 2016 | 4 | 0.450 |
Why?
| | Cerebral Cortex | 3 | 2012 | 123 | 0.440 |
Why?
| | Emotional Adjustment | 1 | 2016 | 1 | 0.440 |
Why?
| | Choline Kinase | 1 | 2015 | 1 | 0.440 |
Why?
| | Child, Institutionalized | 2 | 2015 | 3 | 0.440 |
Why?
| | Molecular Chaperones | 1 | 2015 | 5 | 0.440 |
Why?
| | Maternal Behavior | 1 | 2016 | 9 | 0.440 |
Why?
| | Molecular Targeted Therapy | 1 | 2015 | 8 | 0.440 |
Why?
| | Receptors, Androgen | 1 | 2015 | 11 | 0.430 |
Why?
| | Genetic Markers | 7 | 2010 | 24 | 0.430 |
Why?
| | Prostatectomy | 1 | 2015 | 41 | 0.430 |
Why?
| | DNA Copy Number Variations | 2 | 2012 | 7 | 0.430 |
Why?
| | Adoption | 1 | 2015 | 1 | 0.430 |
Why?
| | Biomedical Research | 1 | 2015 | 21 | 0.430 |
Why?
| | Telencephalon | 1 | 2015 | 5 | 0.430 |
Why?
| | Consensus | 1 | 2015 | 10 | 0.420 |
Why?
| | Neurogenesis | 1 | 2015 | 8 | 0.420 |
Why?
| | Psychotherapy | 1 | 2015 | 15 | 0.420 |
Why?
| | Educational Status | 2 | 2013 | 54 | 0.420 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 46 | 0.420 |
Why?
| | United States | 7 | 2016 | 441 | 0.420 |
Why?
| | Twins | 2 | 2012 | 7 | 0.420 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 65 | 0.410 |
Why?
| | Semantics | 3 | 2013 | 26 | 0.410 |
Why?
| | Child Care | 1 | 2015 | 1 | 0.410 |
Why?
| | Child, Abandoned | 1 | 2015 | 2 | 0.410 |
Why?
| | Orphanages | 1 | 2015 | 4 | 0.410 |
Why?
| | Foster Home Care | 1 | 2015 | 6 | 0.410 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2014 | 15 | 0.410 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2014 | 3 | 0.410 |
Why?
| | Hydrocortisone | 1 | 2014 | 12 | 0.400 |
Why?
| | Cognition Disorders | 3 | 2016 | 193 | 0.400 |
Why?
| | Maternal-Fetal Relations | 1 | 2014 | 4 | 0.400 |
Why?
| | Substance-Related Disorders | 1 | 2015 | 116 | 0.390 |
Why?
| | Poverty | 1 | 2014 | 19 | 0.390 |
Why?
| | Prostatic Neoplasms | 1 | 2015 | 120 | 0.390 |
Why?
| | Developing Countries | 2 | 2015 | 10 | 0.390 |
Why?
| | Microcephaly | 1 | 2014 | 1 | 0.390 |
Why?
| | Prisons | 1 | 2014 | 4 | 0.390 |
Why?
| | Codon, Nonsense | 1 | 2014 | 2 | 0.390 |
Why?
| | Homozygote | 1 | 2014 | 11 | 0.390 |
Why?
| | Cannabis | 1 | 2014 | 16 | 0.390 |
Why?
| | Choline | 1 | 2014 | 1 | 0.390 |
Why?
| | DNA Probes | 2 | 2013 | 17 | 0.390 |
Why?
| | Models, Educational | 2 | 2011 | 10 | 0.390 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 14 | 0.390 |
Why?
| | Glutamic Acid | 1 | 2014 | 19 | 0.390 |
Why?
| | Body Mass Index | 1 | 2014 | 99 | 0.380 |
Why?
| | Stress, Psychological | 2 | 2012 | 137 | 0.380 |
Why?
| | Blood Platelets | 2 | 2005 | 24 | 0.380 |
Why?
| | Chromosomes, Human, Pair 17 | 2 | 2011 | 6 | 0.380 |
Why?
| | Marijuana Smoking | 1 | 2014 | 35 | 0.380 |
Why?
| | Hippocampus | 5 | 2016 | 97 | 0.370 |
Why?
| | Auditory Perception | 1 | 2014 | 31 | 0.370 |
Why?
| | Carrier Proteins | 1 | 2014 | 70 | 0.370 |
Why?
| | Schools | 1 | 2013 | 25 | 0.370 |
Why?
| | Mental Processes | 2 | 2010 | 24 | 0.370 |
Why?
| | Memory, Short-Term | 1 | 2014 | 55 | 0.370 |
Why?
| | Educational Measurement | 1 | 2013 | 45 | 0.360 |
Why?
| | Case-Control Studies | 5 | 2014 | 146 | 0.360 |
Why?
| | Visual Perception | 2 | 2012 | 174 | 0.360 |
Why?
| | Adolescent Behavior | 1 | 2013 | 25 | 0.360 |
Why?
| | Organic Anion Transporters, ATP-Dependent | 1 | 2013 | 1 | 0.360 |
Why?
| | Signal Transduction | 1 | 2015 | 355 | 0.360 |
Why?
| | Publishing | 1 | 2012 | 4 | 0.360 |
Why?
| | Mosaicism | 1 | 2012 | 1 | 0.360 |
Why?
| | Lymphocytes | 1 | 2012 | 18 | 0.360 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2012 | 3 | 0.350 |
Why?
| | Pituitary-Adrenal System | 1 | 2012 | 4 | 0.350 |
Why?
| | Aged | 5 | 2016 | 1145 | 0.350 |
Why?
| | Embryonic Stem Cells | 1 | 2013 | 28 | 0.350 |
Why?
| | Eye | 1 | 2013 | 41 | 0.350 |
Why?
| | Skin | 1 | 2012 | 33 | 0.350 |
Why?
| | Verbal Behavior | 1 | 2012 | 45 | 0.340 |
Why?
| | Translocation, Genetic | 1 | 2011 | 7 | 0.330 |
Why?
| | Smith-Magenis Syndrome | 1 | 2011 | 3 | 0.330 |
Why?
| | Maternal Deprivation | 1 | 2011 | 4 | 0.330 |
Why?
| | Reproducibility of Results | 5 | 2013 | 500 | 0.330 |
Why?
| | Connecticut | 4 | 2015 | 11 | 0.330 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2011 | 5 | 0.330 |
Why?
| | Prefrontal Cortex | 1 | 2012 | 17 | 0.330 |
Why?
| | Impulsive Behavior | 1 | 2012 | 18 | 0.330 |
Why?
| | Membrane Transport Proteins | 1 | 2011 | 9 | 0.330 |
Why?
| | Evolution, Molecular | 2 | 2004 | 99 | 0.320 |
Why?
| | Phylogeny | 2 | 2010 | 118 | 0.320 |
Why?
| | Nervous System Diseases | 1 | 2011 | 14 | 0.310 |
Why?
| | Mathematics | 1 | 2011 | 79 | 0.310 |
Why?
| | Stem Cell Research | 1 | 2011 | 1 | 0.310 |
Why?
| | Neuropsychiatry | 1 | 2011 | 1 | 0.310 |
Why?
| | Character | 1 | 2010 | 5 | 0.310 |
Why?
| | Brain Diseases | 1 | 2011 | 18 | 0.310 |
Why?
| | Checklist | 1 | 2010 | 12 | 0.310 |
Why?
| | Selection, Genetic | 3 | 2011 | 55 | 0.290 |
Why?
| | Chromosome Inversion | 1 | 2010 | 7 | 0.290 |
Why?
| | Polymerase Chain Reaction | 5 | 2012 | 109 | 0.290 |
Why?
| | Chromosomes, Human, Pair 15 | 3 | 2011 | 4 | 0.280 |
Why?
| | Dopamine | 1 | 2010 | 121 | 0.280 |
Why?
| | Pedigree | 5 | 2014 | 17 | 0.280 |
Why?
| | Chromosome Mapping | 8 | 2003 | 50 | 0.270 |
Why?
| | GABA Plasma Membrane Transport Proteins | 1 | 2009 | 3 | 0.270 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 8 | 0.270 |
Why?
| | Aptitude Tests | 1 | 2008 | 5 | 0.270 |
Why?
| | Remedial Teaching | 1 | 2008 | 10 | 0.270 |
Why?
| | Concept Formation | 1 | 2008 | 13 | 0.270 |
Why?
| | Counseling | 2 | 1998 | 14 | 0.270 |
Why?
| | Fibroblast Growth Factors | 1 | 2008 | 13 | 0.270 |
Why?
| | Microsatellite Repeats | 4 | 2011 | 15 | 0.260 |
Why?
| | Outcome Assessment (Health Care) | 1 | 2008 | 31 | 0.260 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 1998 | 46 | 0.260 |
Why?
| | Computer Simulation | 4 | 2008 | 277 | 0.260 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 1 | 0.250 |
Why?
| | Algorithms | 1 | 2011 | 395 | 0.250 |
Why?
| | Behavior | 1 | 2008 | 21 | 0.250 |
Why?
| | Psychometrics | 4 | 2012 | 152 | 0.250 |
Why?
| | Violence | 2 | 2010 | 12 | 0.240 |
Why?
| | Schizophrenia | 2 | 2009 | 111 | 0.240 |
Why?
| | Asperger Syndrome | 2 | 2008 | 5 | 0.240 |
Why?
| | Cell Line | 3 | 2014 | 266 | 0.240 |
Why?
| | Vocabulary | 3 | 2015 | 25 | 0.240 |
Why?
| | Crime | 3 | 2015 | 8 | 0.230 |
Why?
| | Infant | 3 | 2015 | 151 | 0.230 |
Why?
| | Calcium | 2 | 2005 | 164 | 0.230 |
Why?
| | Analysis of Variance | 4 | 2015 | 253 | 0.230 |
Why?
| | Culture | 2 | 2004 | 29 | 0.230 |
Why?
| | Recombination, Genetic | 2 | 2004 | 19 | 0.220 |
Why?
| | Forensic Genetics | 1 | 2005 | 1 | 0.220 |
Why?
| | DNA Fingerprinting | 1 | 2005 | 4 | 0.220 |
Why?
| | Alcohol Dehydrogenase | 1 | 2005 | 2 | 0.220 |
Why?
| | Psychological Trauma | 2 | 2015 | 2 | 0.220 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 5 | 0.220 |
Why?
| | Memory | 2 | 2016 | 107 | 0.220 |
Why?
| | Base Sequence | 4 | 2013 | 308 | 0.220 |
Why?
| | Ryanodine | 1 | 2005 | 1 | 0.210 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2005 | 3 | 0.210 |
Why?
| | Internal-External Control | 1 | 2005 | 25 | 0.210 |
Why?
| | Mice | 3 | 2015 | 1116 | 0.210 |
Why?
| | Health Status | 3 | 2015 | 50 | 0.210 |
Why?
| | Alcoholism | 1 | 2005 | 61 | 0.210 |
Why?
| | Neuroprotective Agents | 1 | 2005 | 29 | 0.210 |
Why?
| | Trinucleotide Repeats | 1 | 2004 | 2 | 0.200 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2015 | 170 | 0.200 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2004 | 2 | 0.200 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2004 | 3 | 0.190 |
Why?
| | Genetic Drift | 1 | 2004 | 4 | 0.190 |
Why?
| | Extracellular Matrix Proteins | 1 | 2004 | 9 | 0.190 |
Why?
| | Saliva | 2 | 2014 | 10 | 0.190 |
Why?
| | Verbal Learning | 3 | 2011 | 52 | 0.180 |
Why?
| | Statistics as Topic | 3 | 2010 | 67 | 0.180 |
Why?
| | Mental Recall | 2 | 2015 | 41 | 0.180 |
Why?
| | Genetics, Medical | 1 | 2003 | 2 | 0.180 |
Why?
| | Electroencephalography | 2 | 2015 | 158 | 0.180 |
Why?
| | Pattern Recognition, Visual | 1 | 2003 | 107 | 0.180 |
Why?
| | Pregnancy | 2 | 2015 | 158 | 0.180 |
Why?
| | Psychiatry | 1 | 2003 | 10 | 0.180 |
Why?
| | RNA, Messenger | 3 | 2013 | 230 | 0.180 |
Why?
| | Fibroblasts | 2 | 2013 | 46 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 109 | 0.170 |
Why?
| | Family Health | 4 | 2008 | 12 | 0.170 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2014 | 63 | 0.170 |
Why?
| | DNA Mutational Analysis | 3 | 2008 | 24 | 0.170 |
Why?
| | Specialization | 1 | 2001 | 6 | 0.170 |
Why?
| | Interprofessional Relations | 1 | 2001 | 12 | 0.170 |
Why?
| | Psychology | 1 | 2001 | 11 | 0.170 |
Why?
| | Sex Factors | 3 | 2015 | 167 | 0.170 |
Why?
| | Homeodomain Proteins | 1 | 2002 | 83 | 0.160 |
Why?
| | HIV Seropositivity | 2 | 1998 | 16 | 0.160 |
Why?
| | Cells, Cultured | 2 | 2013 | 340 | 0.160 |
Why?
| | African Americans | 2 | 2016 | 103 | 0.160 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2001 | 11 | 0.160 |
Why?
| | Receptors, GABA-B | 1 | 2001 | 2 | 0.160 |
Why?
| | Predictive Value of Tests | 2 | 2014 | 166 | 0.160 |
Why?
| | Photic Stimulation | 2 | 2012 | 268 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2001 | 7 | 0.160 |
Why?
| | Cell Differentiation | 2 | 2012 | 142 | 0.160 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2011 | 23 | 0.160 |
Why?
| | Immunohistochemistry | 3 | 2013 | 170 | 0.150 |
Why?
| | Psychological Tests | 3 | 2014 | 46 | 0.150 |
Why?
| | Cross-Sectional Studies | 2 | 2014 | 220 | 0.150 |
Why?
| | Transcription Factors | 1 | 2002 | 221 | 0.150 |
Why?
| | Phenylalanine Hydroxylase | 1 | 2000 | 1 | 0.150 |
Why?
| | DNA Primers | 3 | 2009 | 69 | 0.150 |
Why?
| | Pilot Projects | 2 | 2013 | 99 | 0.150 |
Why?
| | Receptors, Dopamine D2 | 2 | 2001 | 25 | 0.150 |
Why?
| | Follow-Up Studies | 2 | 2013 | 275 | 0.140 |
Why?
| | Mutation | 1 | 2001 | 254 | 0.140 |
Why?
| | Cell Culture Techniques | 2 | 2013 | 34 | 0.140 |
Why?
| | Attitude to Death | 1 | 1998 | 2 | 0.140 |
Why?
| | Grief | 1 | 1998 | 2 | 0.140 |
Why?
| | Disease Outbreaks | 1 | 1998 | 10 | 0.130 |
Why?
| | Women's Health | 1 | 1998 | 12 | 0.130 |
Why?
| | Neoplasm Proteins | 2 | 2013 | 37 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1998 | 59 | 0.130 |
Why?
| | Disabled Children | 1 | 1998 | 1 | 0.130 |
Why?
| | Education of Intellectually Disabled | 1 | 1998 | 2 | 0.130 |
Why?
| | Politics | 1 | 1998 | 6 | 0.130 |
Why?
| | Receptors, Glutamate | 1 | 1997 | 6 | 0.130 |
Why?
| | Epilepsy | 1 | 1997 | 43 | 0.120 |
Why?
| | Minisatellite Repeats | 2 | 2009 | 4 | 0.120 |
Why?
| | Rejection (Psychology) | 2 | 2008 | 3 | 0.120 |
Why?
| | Molecular Sequence Data | 3 | 2009 | 383 | 0.120 |
Why?
| | Receptors, Nicotinic | 1 | 1997 | 15 | 0.120 |
Why?
| | Spinal Cord | 1 | 1997 | 31 | 0.120 |
Why?
| | Motor Neurons | 1 | 1997 | 19 | 0.120 |
Why?
| | Far East | 2 | 2011 | 2 | 0.120 |
Why?
| | Lod Score | 2 | 2011 | 3 | 0.120 |
Why?
| | Monte Carlo Method | 1 | 1996 | 23 | 0.120 |
Why?
| | Time Factors | 2 | 2014 | 709 | 0.110 |
Why?
| | Comorbidity | 2 | 2011 | 129 | 0.110 |
Why?
| | Neuronal Plasticity | 1 | 2016 | 42 | 0.110 |
Why?
| | Heterozygote | 2 | 2010 | 21 | 0.110 |
Why?
| | Neoplasm Grading | 1 | 2015 | 5 | 0.110 |
Why?
| | War Exposure | 1 | 2015 | 1 | 0.110 |
Why?
| | Exposure to Violence | 1 | 2015 | 1 | 0.110 |
Why?
| | Pregnancy in Adolescence | 1 | 2015 | 1 | 0.110 |
Why?
| | Malnutrition | 1 | 2015 | 1 | 0.110 |
Why?
| | Nodding Syndrome | 1 | 2015 | 1 | 0.110 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 17 | 0.110 |
Why?
| | Mice, SCID | 1 | 2015 | 17 | 0.110 |
Why?
| | Epistasis, Genetic | 1 | 2015 | 3 | 0.110 |
Why?
| | Intimate Partner Violence | 1 | 2015 | 2 | 0.110 |
Why?
| | Neurotoxins | 1 | 2015 | 4 | 0.110 |
Why?
| | Malaria | 1 | 2015 | 10 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 26 | 0.110 |
Why?
| | Neurocognitive Disorders | 1 | 2015 | 12 | 0.110 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 24 | 0.110 |
Why?
| | Neoplasm Staging | 1 | 2015 | 59 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 58 | 0.110 |
Why?
| | Universities | 1 | 2016 | 45 | 0.110 |
Why?
| | Megalencephaly | 1 | 2015 | 1 | 0.110 |
Why?
| | Organoids | 1 | 2015 | 4 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2015 | 50 | 0.110 |
Why?
| | Hydrocephalus | 1 | 2015 | 63 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 103 | 0.100 |
Why?
| | Parents | 1 | 2015 | 40 | 0.100 |
Why?
| | Brain Injuries | 1 | 2015 | 62 | 0.100 |
Why?
| | Age Factors | 1 | 2015 | 224 | 0.100 |
Why?
| | Body Height | 1 | 2014 | 8 | 0.100 |
Why?
| | Health Status Indicators | 1 | 2014 | 13 | 0.100 |
Why?
| | Social Skills | 1 | 2014 | 3 | 0.100 |
Why?
| | Aged, 80 and over | 1 | 2016 | 397 | 0.100 |
Why?
| | Aspartic Acid | 1 | 2014 | 9 | 0.100 |
Why?
| | Body Weight | 1 | 2014 | 99 | 0.100 |
Why?
| | Speech Discrimination Tests | 1 | 2014 | 4 | 0.100 |
Why?
| | Retrospective Studies | 1 | 2015 | 340 | 0.100 |
Why?
| | Prevalence | 1 | 2014 | 129 | 0.090 |
Why?
| | DNA | 2 | 2005 | 128 | 0.090 |
Why?
| | Genotyping Techniques | 1 | 2013 | 2 | 0.090 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2013 | 39 | 0.090 |
Why?
| | Acyclovir | 1 | 2013 | 1 | 0.090 |
Why?
| | Organic Anion Transporters, Sodium-Independent | 1 | 2013 | 1 | 0.090 |
Why?
| | Models, Biological | 1 | 2015 | 301 | 0.090 |
Why?
| | Foreskin | 1 | 2013 | 1 | 0.090 |
Why?
| | USSR | 1 | 2012 | 2 | 0.090 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 6 | 0.090 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2013 | 12 | 0.090 |
Why?
| | Autopsy | 1 | 2012 | 1 | 0.090 |
Why?
| | Cellular Reprogramming | 1 | 2012 | 3 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2012 | 5 | 0.090 |
Why?
| | Clone Cells | 1 | 2012 | 15 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 35 | 0.090 |
Why?
| | History, 20th Century | 1 | 2012 | 48 | 0.090 |
Why?
| | Cattle | 1 | 2012 | 81 | 0.090 |
Why?
| | HIV Infections | 1 | 2015 | 190 | 0.090 |
Why?
| | Transcriptome | 1 | 2012 | 14 | 0.090 |
Why?
| | Sequence Analysis, RNA | 1 | 2012 | 19 | 0.090 |
Why?
| | Tandem Repeat Sequences | 2 | 2004 | 5 | 0.090 |
Why?
| | In Vitro Techniques | 1 | 2013 | 224 | 0.090 |
Why?
| | Factor Analysis, Statistical | 1 | 2012 | 39 | 0.080 |
Why?
| | Gyrus Cinguli | 1 | 2012 | 2 | 0.080 |
Why?
| | Semaphorins | 1 | 2011 | 1 | 0.080 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2011 | 2 | 0.080 |
Why?
| | Chromosome Breakpoints | 1 | 2011 | 2 | 0.080 |
Why?
| | Psycholinguistics | 1 | 2012 | 5 | 0.080 |
Why?
| | Globus Pallidus | 1 | 2012 | 5 | 0.080 |
Why?
| | Chromosome Disorders | 1 | 2011 | 2 | 0.080 |
Why?
| | Chromosome Duplication | 1 | 2011 | 2 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 2013 | 168 | 0.080 |
Why?
| | CpG Islands | 1 | 2011 | 7 | 0.080 |
Why?
| | Skin Pigmentation | 1 | 2011 | 2 | 0.080 |
Why?
| | Europe | 1 | 2011 | 8 | 0.080 |
Why?
| | Abnormalities, Multiple | 1 | 2011 | 16 | 0.080 |
Why?
| | Eye Color | 1 | 2011 | 9 | 0.080 |
Why?
| | Cornea | 1 | 2013 | 115 | 0.080 |
Why?
| | Parietal Lobe | 1 | 2012 | 30 | 0.080 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2011 | 1 | 0.080 |
Why?
| | Visual Cortex | 1 | 2012 | 101 | 0.080 |
Why?
| | Genomic Structural Variation | 1 | 2011 | 1 | 0.080 |
Why?
| | Occipital Lobe | 1 | 2011 | 11 | 0.080 |
Why?
| | Diseases in Twins | 1 | 2011 | 6 | 0.080 |
Why?
| | Pluripotent Stem Cells | 1 | 2011 | 7 | 0.080 |
Why?
| | Bias (Epidemiology) | 1 | 2010 | 17 | 0.080 |
Why?
| | Psychomotor Performance | 1 | 2012 | 146 | 0.080 |
Why?
| | Exons | 2 | 2001 | 20 | 0.080 |
Why?
| | Communication Disorders | 1 | 2010 | 1 | 0.080 |
Why?
| | DiGeorge Syndrome | 1 | 2010 | 2 | 0.080 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2012 | 94 | 0.080 |
Why?
| | Observer Variation | 1 | 2010 | 65 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2011 | 113 | 0.080 |
Why?
| | Chi-Square Distribution | 2 | 2002 | 35 | 0.080 |
Why?
| | Retina | 1 | 2013 | 290 | 0.080 |
Why?
| | Sample Size | 2 | 2000 | 6 | 0.070 |
Why?
| | Ireland | 1 | 2010 | 3 | 0.070 |
Why?
| | Poisson Distribution | 1 | 2010 | 7 | 0.070 |
Why?
| | Primates | 1 | 2010 | 15 | 0.070 |
Why?
| | Neural Pathways | 1 | 2010 | 65 | 0.070 |
Why?
| | Forecasting | 2 | 2001 | 35 | 0.070 |
Why?
| | Gambia | 1 | 2009 | 1 | 0.070 |
Why?
| | Rats | 2 | 2005 | 833 | 0.070 |
Why?
| | Intelligence Tests | 2 | 2004 | 41 | 0.070 |
Why?
| | Logistic Models | 1 | 2010 | 123 | 0.070 |
Why?
| | Socioeconomic Factors | 1 | 2009 | 93 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2011 | 312 | 0.070 |
Why?
| | Mainstreaming (Education) | 1 | 2008 | 1 | 0.070 |
Why?
| | Pharmacogenetics | 1 | 2009 | 12 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2009 | 42 | 0.070 |
Why?
| | Task Performance and Analysis | 1 | 2009 | 43 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 1 | 2009 | 25 | 0.070 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2001 | 2 | 0.070 |
Why?
| | Genetics, Behavioral | 1 | 2008 | 5 | 0.070 |
Why?
| | Genome | 1 | 2009 | 24 | 0.070 |
Why?
| | Principal Component Analysis | 1 | 2008 | 15 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2009 | 49 | 0.070 |
Why?
| | Netherlands | 1 | 2008 | 4 | 0.070 |
Why?
| | Recombinant Proteins | 1 | 2009 | 90 | 0.070 |
Why?
| | Seizures | 1 | 2008 | 13 | 0.070 |
Why?
| | Cues | 1 | 2009 | 77 | 0.070 |
Why?
| | Social Behavior | 1 | 2008 | 52 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2008 | 99 | 0.060 |
Why?
| | Receptors, Prolactin | 1 | 2008 | 1 | 0.060 |
Why?
| | Receptors, Oxytocin | 1 | 2008 | 1 | 0.060 |
Why?
| | Organizational Affiliation | 1 | 2008 | 2 | 0.060 |
Why?
| | Prolactin | 1 | 2008 | 8 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2008 | 11 | 0.060 |
Why?
| | Oxytocin | 1 | 2008 | 5 | 0.060 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2008 | 1 | 0.060 |
Why?
| | Prognosis | 1 | 2008 | 146 | 0.060 |
Why?
| | Software | 2 | 2000 | 84 | 0.060 |
Why?
| | Odds Ratio | 1 | 2008 | 51 | 0.060 |
Why?
| | Cohort Studies | 1 | 2008 | 175 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2009 | 127 | 0.060 |
Why?
| | Helminthiasis | 1 | 2007 | 2 | 0.060 |
Why?
| | Vitamins | 1 | 2007 | 2 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 149 | 0.060 |
Why?
| | Underachievement | 1 | 2006 | 3 | 0.060 |
Why?
| | Regression Analysis | 1 | 2007 | 178 | 0.060 |
Why?
| | Interview, Psychological | 1 | 2005 | 20 | 0.050 |
Why?
| | Exploratory Behavior | 1 | 2005 | 22 | 0.050 |
Why?
| | Benzoxazines | 1 | 2005 | 1 | 0.050 |
Why?
| | Okadaic Acid | 1 | 2005 | 2 | 0.050 |
Why?
| | Dantrolene | 1 | 2005 | 2 | 0.050 |
Why?
| | Thionucleotides | 1 | 2005 | 3 | 0.050 |
Why?
| | Estrenes | 1 | 2005 | 4 | 0.050 |
Why?
| | Cyclohexanols | 1 | 2005 | 2 | 0.050 |
Why?
| | Oxazoles | 1 | 2005 | 6 | 0.050 |
Why?
| | Naphthalenes | 1 | 2005 | 3 | 0.050 |
Why?
| | Pyrrolidinones | 1 | 2005 | 12 | 0.050 |
Why?
| | Macrocyclic Compounds | 1 | 2005 | 5 | 0.050 |
Why?
| | N-Methylaspartate | 1 | 2005 | 19 | 0.050 |
Why?
| | Fetus | 1 | 2005 | 17 | 0.050 |
Why?
| | Morpholines | 1 | 2005 | 8 | 0.050 |
Why?
| | Piperidines | 1 | 2005 | 15 | 0.050 |
Why?
| | Rats, Inbred Strains | 1 | 2005 | 106 | 0.050 |
Why?
| | Cell Death | 1 | 2005 | 30 | 0.050 |
Why?
| | Drug Interactions | 1 | 2005 | 56 | 0.050 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2005 | 29 | 0.050 |
Why?
| | Pyrazoles | 1 | 2005 | 19 | 0.050 |
Why?
| | Ethnic Groups | 1 | 2005 | 59 | 0.050 |
Why?
| | Research | 1 | 2005 | 17 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2005 | 24 | 0.050 |
Why?
| | Research Design | 1 | 2005 | 47 | 0.050 |
Why?
| | Cyclic AMP | 1 | 2005 | 123 | 0.050 |
Why?
| | Databases, Genetic | 1 | 2004 | 17 | 0.050 |
Why?
| | Serine Endopeptidases | 1 | 2004 | 6 | 0.050 |
Why?
| | Hominidae | 1 | 2004 | 1 | 0.050 |
Why?
| | Nuclear Family | 1 | 2002 | 2 | 0.040 |
Why?
| | Sweden | 1 | 2002 | 1 | 0.040 |
Why?
| | Causality | 1 | 2001 | 11 | 0.040 |
Why?
| | Sclerosis | 1 | 2001 | 3 | 0.040 |
Why?
| | Cell Size | 1 | 2001 | 17 | 0.040 |
Why?
| | Pyramidal Cells | 1 | 2001 | 15 | 0.040 |
Why?
| | Cell Count | 1 | 2001 | 46 | 0.040 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 2001 | 2 | 0.040 |
Why?
| | Introns | 1 | 2001 | 20 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2001 | 17 | 0.040 |
Why?
| | Smoking | 1 | 2005 | 303 | 0.040 |
Why?
| | Twin Studies as Topic | 1 | 2001 | 1 | 0.040 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2001 | 2 | 0.040 |
Why?
| | Population Growth | 1 | 2001 | 5 | 0.040 |
Why?
| | Personality Disorders | 1 | 2001 | 8 | 0.040 |
Why?
| | Syndrome | 1 | 2001 | 23 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 40 | 0.040 |
Why?
| | Environment | 1 | 2001 | 26 | 0.040 |
Why?
| | Africa | 1 | 2000 | 2 | 0.040 |
Why?
| | Indians, North American | 1 | 2000 | 6 | 0.040 |
Why?
| | Likelihood Functions | 1 | 2000 | 26 | 0.040 |
Why?
| | Community Mental Health Services | 1 | 1998 | 5 | 0.030 |
Why?
| | AIDS Serodiagnosis | 1 | 1998 | 4 | 0.030 |
Why?
| | Life Change Events | 1 | 1998 | 46 | 0.030 |
Why?
| | Sexual Behavior | 1 | 1998 | 38 | 0.030 |
Why?
| | Risk Assessment | 1 | 1998 | 97 | 0.030 |
Why?
| | Self Concept | 1 | 1998 | 46 | 0.030 |
Why?
| | Health Policy | 1 | 1998 | 11 | 0.030 |
Why?
| | Referral and Consultation | 1 | 1998 | 27 | 0.030 |
Why?
| | Drug Resistance | 1 | 1997 | 10 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1997 | 12 | 0.030 |
Why?
| | Receptors, Kainic Acid | 1 | 1997 | 2 | 0.030 |
Why?
| | Oligonucleotides | 1 | 1997 | 17 | 0.030 |
Why?
| | Prospective Studies | 1 | 1998 | 249 | 0.030 |
Why?
| | Receptors, AMPA | 1 | 1997 | 15 | 0.030 |
Why?
| | Aconitine | 1 | 1997 | 2 | 0.030 |
Why?
| | Egtazic Acid | 1 | 1997 | 4 | 0.030 |
Why?
| | Acetylcholine | 1 | 1997 | 14 | 0.030 |
Why?
| | Cell Survival | 1 | 1997 | 73 | 0.030 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 1997 | 1 | 0.030 |
Why?
| | Probability | 1 | 1997 | 30 | 0.030 |
Why?
| | Nicotine | 1 | 1997 | 57 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1995 | 20 | 0.030 |
Why?
| | Personality Inventory | 1 | 1995 | 60 | 0.030 |
Why?
| | Biological Evolution | 1 | 1995 | 70 | 0.030 |
Why?
| | Twins, Dizygotic | 1 | 1992 | 3 | 0.020 |
Why?
| | Twins, Monozygotic | 1 | 1992 | 7 | 0.020 |
Why?
| | Psychology, Adolescent | 1 | 1992 | 9 | 0.020 |
Why?
| | Imagination | 1 | 1992 | 7 | 0.020 |
Why?
|
|
Grigorenko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|